CODX Co-Diagnostics, Inc. Stock Quote

CODX [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	5.20	EPS (ttm)	1.56	Insider Own	0.10%	Shs Outstand	28.79M	Perf Week	-5.68%
Market Cap	239.43M	Forward P/E	15.54	EPS next Y	0.52	Insider Trans	-78.93%	Shs Float	27.11M	Perf Month	-17.29%
Income	46.20M	PEG	-	EPS next Q	0.21	Inst Own	27.50%	Short Float	7.93%	Perf Quarter	-17.29%
Sales	96.30M	P/S	2.49	EPS this Y	510.30%	Inst Trans	3.57%	Short Ratio	2.57	Perf Half Y	-8.45%
Book/sh	3.03	P/B	2.68	EPS next Y	-46.63%	ROA	61.70%	Target Price	22.50	Perf Year	-42.87%
Cash/sh	2.46	P/C	3.31	EPS next 5Y	-	ROE	65.30%	52W Range	7.01 - 20.69	Perf YTD	-12.58%
Dividend	-	P/FCF	4.59	EPS past 5Y	55.00%	ROI	62.40%	52W High	-60.70%	Beta	-1.84
Dividend %	-	Quick Ratio	18.20	Sales past 5Y	495.00%	Gross Margin	83.50%	52W Low	15.98%	ATR	0.34
Employees	37	Current Ratio	19.10	Sales Q/Q	14.20%	Oper. Margin	52.00%	RSI (14)	32.19	Volatility	3.28% 4.11%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-36.10%	Profit Margin	48.00%	Rel Volume	0.18	Prev Close	8.30
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 12 AMC	Payout	0.00%	Avg Volume	838.25K	Price	8.13
Recom	2.30	SMA20	-6.35%	SMA50	-15.98%	SMA200	-21.26%	Volume	154,232	Change	-2.05%

Mar-29-21

Downgrade

Maxim Group

Buy → Hold

May-20-20

Upgrade

Maxim Group

Hold → Buy

May-18-20

Reiterated

H.C. Wainwright

Buy

$20 → $35

Mar-09-20

Reiterated

H.C. Wainwright

Buy

$4 → $20

Mar-03-20

Downgrade

Maxim Group

Buy → Hold

Oct-13-21 08:00AM	Investing in Co-Diagnostics (NASDAQ:CODX) three years ago would have delivered you a 230% gain Simply Wall St.
Oct-06-21 10:54AM	Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for Dengue/Chikungunya Multiplex Test PR Newswire
Sep-27-21 09:30AM	Co-Diagnostics, Inc. to Introduce At Home/Point of Care Device at AACC on Sept 28 PR Newswire
Sep-23-21 09:30AM	Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion PR Newswire
Sep-21-21 04:15PM	Co-Diagnostics, Inc. to Present at ACTC Liquid Biopsy Conference in Kalamata, Greece PR Newswire
09:30AM	Co-Diagnostics, Inc. Logix Smart ABC Test Authorized for Use in Mexico PR Newswire
07:35AM	Sidoti Fall Virtual Small Cap Investor Conference ACCESSWIRE
Sep-20-21 05:03PM	Co-Diagnostics, Inc. to Present at Sidoti Virtual Investor Conference PR Newswire
Sep-16-21 09:30AM	Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests PR Newswire
Sep-13-21 06:30AM	Co-Diagnostics, Inc. CEO to Participate in Panel Discussion with Scott Gottlieb, M.D., at H.C. Wainwright 2021 Annual Global Investor Conference PR Newswire -5.29%
Sep-08-21 09:30AM	Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy PR Newswire
Aug-23-21 09:30AM	Co-Diagnostics, Inc. To Present At 13th Next Generation Dx Summit In Washington, D.C. PR Newswire
Aug-14-21 03:19AM	Co-Diagnostics, Inc. (NASDAQ:CODX) Surges 42% Yet Its Low P/E Is No Reason For Excitement Simply Wall St.
Aug-13-21 05:47PM	Why Co-Diagnostics Zoomed Almost 10% Higher Today Motley Fool +9.62%
04:21PM	Co-Diagnostics Stock Surges As Variants Drive Covid Test Demand Investor's Business Daily
02:03AM	Are Robust Financials Driving The Recent Rally In Co-Diagnostics, Inc.'s (NASDAQ:CODX) Stock? Simply Wall St.
Aug-12-21 04:01PM	Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results PR Newswire
Aug-04-21 11:30AM	Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast PR Newswire
Jul-22-21 06:28PM	Why Co-Diagnostics Blasted 21% Higher on Thursday Motley Fool +21.15%
09:30AM	Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer Patent PR Newswire
Jun-18-21 12:11PM	Co-Diagnostics, Inc. (CODX) Fell Out Of Favor With Hedge Funds Insider Monkey
10:30AM	Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test PR Newswire
Jun-15-21 09:30AM	Co-Diagnostics, Inc. to Present at Upcoming Technology and Health Research Conferences PR Newswire
May-15-21 03:45AM	Earnings Beat: Co-Diagnostics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Simply Wall St.
May-13-21 02:30PM	Co-Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
May-04-21 09:30AM	Co-Diagnostics, Inc. Announces First-Quarter 2021 Earnings Release Date and Webcast PR Newswire
Apr-29-21 09:30AM	Co-Diagnostics, Inc. and Partner CRL to Discuss Saliva Testing and Future Applications of PCR in 360Dx Webinar PR Newswire
Apr-28-21 09:30AM	Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India PR Newswire
Apr-27-21 05:06AM	SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of EQT, APO, GSKY, and CODX; Shareholders are Encouraged to Contact the Firm GlobeNewswire
Apr-20-21 09:30AM	Co-Diagnostics, Inc. Test Performance Demonstrated by Australian Researchers in Peer-Reviewed Publication PR Newswire -6.93%
Mar-31-21 09:30AM	Co-Diagnostics, Inc. CEO Discusses Company Strategy for the Future with Yahoo! Finance PR Newswire +11.71%
Mar-30-21 05:18PM	'We believe robust testing will be required in order to normalize' post-pandemic: Co-Diagnostics CEO Yahoo Finance Video
01:13AM	Some Co-Diagnostics, Inc. (NASDAQ:CODX) Analysts Just Made A Major Cut To Next Year's Estimates Simply Wall St.
Mar-29-21 04:42PM	Co-Diagnostics: Buy the Dip? Motley Fool -12.16%
04:09PM	Why Co-Diagnostics Stock Is Dropping Today Motley Fool
02:14PM	Co-Diagnostics Sales Will Slow, But the Stock Is Still a Buy, Says Analyst TipRanks
Mar-26-21 10:40AM	Why Co-Diagnostics Stock Is Tanking Today Motley Fool -19.97%
06:00AM	What Investors Didn't Like About Co-Diagnostics' Q4 Update Motley Fool
Mar-25-21 04:19PM	Recap: Co-Diagnostics Q4 Earnings Benzinga
04:01PM	Co-Diagnostics Reports Fourth-Quarter and Full-Year 2020 Financial Results PR Newswire
02:30PM	Co-Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Mar-18-21 08:30AM	Co-Diagnostics, Inc. Announces Fourth-Quarter and Full-Year 2020 Earnings Release Date and Webcast PR Newswire
Mar-16-21 09:30AM	Co-Diagnostics Invited to Present at Maxim Group LLC Emerging Growth Virtual Conference PR Newswire
Mar-14-21 03:18AM	Co-Diagnostics, Inc. (NASDAQ:CODX) Analysts Are Reducing Their Forecasts For Next Year Simply Wall St.
Mar-13-21 01:44AM	Is Co-Diagnostics, Inc. (NASDAQ:CODX) Trading At A 50% Discount? Simply Wall St.
Mar-10-21 09:30AM	Co-Diagnostics to Present Point-of-Care and At Home Testing Platform at Infectious Disease Diagnostics Virtual Conference PR Newswire -7.64%
Mar-08-21 09:30AM	Co-Diagnostics to Discuss Recent Company Advances at H.C. Wainwright Global Life Sciences Virtual Conference PR Newswire
Mar-02-21 09:30AM	Co-Diagnostics New Rapid PCR Point-of-Care and at Home Testing Platform to Detect Covid-19 and Other Diseases Using CoPrimer Technology PR Newswire
Feb-25-21 09:30AM	Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer-Based COVID-19 PCR Test Through Walgreens Find Care® PR Newswire -7.67%
Feb-24-21 03:22PM	Why Co-Diagnostics Stock Is Shooting Higher Today Motley Fool +11.20%
08:03AM	Clinical Reference Laboratory Makes First At-Home COVID-19 Saliva Test Available Through Walgreens Find Care® PR Newswire
Feb-23-21 08:36PM	Co-Diagnostics Names New CFO and CSO Motley Fool -5.18%
09:30AM	Co-Diagnostics, Inc. Announces New Chief Financial Officer PR Newswire
Feb-17-21 12:44PM	Co-Diagnostics Clears Technical Benchmark, Hitting 90-Plus RS Rating Investor's Business Daily -5.51%
Feb-16-21 09:30AM	Co-Diagnostics, Inc. to Present on Direct Saliva Testing Technology at Molecular Med Tri-Con PR Newswire +6.83%
Feb-10-21 01:30PM	Co-Diagnostics Shows Rising Price Performance With Jump To 91 RS Rating Investor's Business Daily -6.56%
Feb-05-21 06:53AM	3 Stocks That Are Absurdly Cheap Right Now Motley Fool
Jan-30-21 12:00AM	Up 938% in 2020, Is Co-Diagnostics Still a Buy in 2021? Motley Fool
Jan-28-21 09:30AM	Co-Diagnostics Completes FDA EUA Submission for Extraction-Free Saliva COVID-19 Test PR Newswire
Jan-25-21 05:35PM	Top 5 Healthcare Stocks of 2020: Are They Buys Now? Motley Fool
Jan-21-21 12:34AM	Co-Diagnostics, Inc.'s (NASDAQ:CODX) Stock's On An Uptrend: Are Strong Financials Guiding The Market? Simply Wall St.
Jan-09-21 08:29AM	These Were the 5 Best Diagnostics Stocks of 2020 Motley Fool
Jan-07-21 09:30AM	Co-Diagnostics to Present at H.C. Wainwright BioConnect 2021 Virtual Conference PR Newswire
Jan-06-21 09:30AM	Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products PR Newswire
Jan-01-21 06:10AM	These Were the 3 Best Coronavirus Stocks of 2020 Motley Fool
Dec-22-20 09:30AM	Co-Diagnostics Designs Test to Detect Mutations for New Coronavirus Strain Using CoPrimer Platform PR Newswire
Dec-14-20 09:30AM	Co-Diagnostics Announces Milestone of Over 10 Million COVID-19 Tests Sold PR Newswire
Dec-10-20 12:44PM	Up 1,000% in 2020, Is Co-Diagnostics Stock Still a Buy? Motley Fool
Dec-01-20 12:22PM	Where Do Hedge Funds Stand On Co-Diagnostics, Inc. (CODX)? Insider Monkey -5.63%
Nov-25-20 03:40PM	Why Co-Diagnostics Stock Jumped Today Motley Fool +14.96%
01:00PM	Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test PR Newswire
Nov-24-20 08:00AM	Maxim Group & H.C. Wainwright Analysts Confirm Co-Diagnostics (NADSAQ:CODX) Buy Rating with PTs of $20 and $29 GlobeNewswire
Nov-22-20 01:52AM	Things Look Grim For Co-Diagnostics, Inc. (NASDAQ:CODX) After Today's Downgrade Simply Wall St.
Nov-17-20 04:43PM	Covid Report: Coronavirus Test Maker Co-Diagnostics Plunges As Sales Lag Investor's Business Daily -12.51%
12:18PM	Why Co-Diagnostics Stock Is Getting Clobbered Today Motley Fool
09:56AM	Dow Jones Today Leads Pullback, Tesla Props Nasdaq; Walgreens, CVS Dive On Amazon Pharmacy Launch Investor's Business Daily
06:30AM	Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex Tests PR Newswire
Nov-16-20 04:27PM	Co-Diagnostics: Q3 Earnings Insights Benzinga -9.28%
04:01PM	Co-Diagnostics, Inc. Announces Q3 2020 Financial Results Including YTD Net Income per Common Share of $1.07 PR Newswire
Nov-11-20 09:13AM	Co-Diagnostics CoPrimers Effective In Covid-19 Saliva Tests; Shares Pop 9% SmarterAnalyst +13.10%
06:30AM	Co-Diagnostics, Inc. CoPrimers Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction PR Newswire
Nov-10-20 06:30AM	Co-Diagnostics, Inc. Announces Q3 2020 Earnings Release Date and Earnings Webcast PR Newswire
Nov-09-20 10:02AM	Co-Diagnostics (CODX) to Post Q3 Earnings: What's in Store? Zacks -20.43%
08:02AM	Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Consumers PR Newswire
Nov-02-20 04:45PM	Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per Share PR Newswire
Oct-29-20 10:15PM	Top Small Cap Stocks for November 2020 Investopedia
Oct-23-20 07:20AM	3 Reasons It's Not Too Late to Buy Co-Diagnostics Motley Fool
Oct-17-20 09:20AM	We Like Co-Diagnostics' (NASDAQ:CODX) Returns And Here's How They're Trending Simply Wall St.
Oct-08-20 09:28AM	Why Co-Diagnostics Stock Soared 25% in September Motley Fool
Oct-07-20 08:39AM	Implied Volatility Surging for Co-Diagnostics (CODX) Stock Options Zacks
Oct-05-20 09:18AM	Company News for Oct 5, 2020 Zacks +6.23%
Oct-02-20 10:55AM	P/E Ratio Insights for Co-Diagnostics Benzinga +7.63%
10:41AM	Why Co-Diagnostics Stock Is Trading Higher Today Benzinga
06:30AM	Co-Diagnostics, Inc. Logix Smart Kit to be Used with Newly Authorized Saline Oral Rinse Collection PR Newswire
Sep-28-20 03:08PM	Co-Diagnostics introduces test that checks for Flu A, B & COVID-19 Yahoo Finance Video
Sep-24-20 11:36AM	Moore Kuehn Encourages Investors of CODX, LVS, or WRTC to Contact Law Firm PR Newswire
08:15AM	The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO Benzinga
06:30AM	Co-Diagnostics, Inc. Provides Update on "ABC" Test for Influenza A, Influenza B, and COVID-19 PR Newswire
Sep-18-20 08:21AM	Is Co-Diagnostics Stock a Buy? Motley Fool
Sep-11-20 02:00PM	Co-Diagnostics, Inc. Announces Details to Access Presentation at H.C. Wainwright Global Investment Conference PR Newswire +17.99%

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and liquid biopsy test for cancer screening. The company also provides tests that identify genetic traits in plant and animal genomes. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Durenard Eugene	Director	Sep 08	Sale	10.46	2,000	20,910	0	Sep 22 11:37 AM
BENSON REED L	General Counsel	May 19	Option Exercise	2.63	108,334	284,917	108,334	May 21 12:43 PM
BENSON REED L	General Counsel	May 19	Sale	8.53	108,334	923,628	0	May 21 12:43 PM
Egan Dwight H	Chief Executive Officer	Jan 15	Option Exercise	2.63	50,000	131,500	50,000	Jan 20 06:48 PM
Egan Dwight H	Chief Executive Officer	Jan 15	Sale	11.00	38,046	418,506	0	Jan 20 06:48 PM
SERBIN RICHARD S	Director	Jan 14	Sale	10.29	10,000	102,900	2,500	Jan 15 05:14 PM
Durenard Eugene	Director	Jan 13	Sale	10.09	10,500	105,945	2,000	Jan 15 01:32 PM
NELSON JAMES B	Director	Jan 13	Sale	10.13	12,500	126,631	0	Jan 15 01:29 PM
SERBIN RICHARD S	Director	Dec 14	Sale	10.10	17,000	171,700	0	Dec 15 06:46 PM
Durenard Eugene	Director	Dec 10	Sale	10.15	10,000	101,500	0	Dec 14 02:35 PM
BENSON REED L	CFO and Secretary	Nov 25	Option Exercise	1.10	100,000	110,000	100,000	Nov 30 10:47 AM
BENSON REED L	CFO and Secretary	Nov 25	Sale	10.50	89,524	940,002	0	Nov 30 10:47 AM
Egan Dwight H	Chief Executive Officer	Nov 24	Option Exercise	1.10	50,000	55,000	50,000	Nov 25 08:56 AM
Egan Dwight H	Chief Executive Officer	Nov 24	Sale	10.51	44,764	470,470	0	Nov 25 08:56 AM
Egan Dwight H	Chief Executive Officer	Nov 23	Option Exercise	1.10	80,000	88,000	80,000	Nov 25 08:56 AM
Egan Dwight H	Chief Executive Officer	Nov 23	Sale	10.44	71,569	747,180	0	Nov 25 08:56 AM
Egan Dwight H	Chief Executive Officer	Nov 20	Option Exercise	1.10	20,000	22,000	20,000	Nov 25 08:56 AM
Egan Dwight H	Chief Executive Officer	Nov 20	Sale	11.09	18,017	199,809	0	Nov 25 08:56 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience